This announcement is a separate document:
北京市中伦律师事务所关于甘李药业股份有限公司2022年限制性股票激励计划第一个解除限售期解除限售条件成就及回购注销部分限制性股票的法律意见书
Legal Opinion of Beijing Zhonglun Law Firm on Ganli Pharmaceutical Co., Ltd.'s 2022 Restricted Stock Incentive Plan to lift the sales restriction period, release the sales restriction conditions, and repurchase and cancel some restricted stocks
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.